Holen Sie sich die Stockscreener-App
3.07
0.65%
-0.02
Schlusskurs vom Vortag:
$3.09
Offen:
$3.19
24-Stunden-Volumen:
14,683
Relative Volume:
0.25
Marktkapitalisierung:
$41.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.59M
KGV:
-2.8426
EPS:
-1.08
Netto-Cashflow:
$-19.79M
1W Leistung:
+1.99%
1M Leistung:
+11.23%
6M Leistung:
-25.67%
1J Leistung:
-35.79%
1-Tages-Spanne:
$2.9217
$3.2077
1-Wochen-Bereich:
$2.9217
$3.2808
52-Wochen-Spanne:
$2.05
$8.38
Calcimedica Inc Stock (CALC) Company Profile
Firmenname
Calcimedica Inc
Sektor
Branche
Telefon
858-952-5500
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Vergleichen Sie CALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
3.07 | 41.39M | 0 | -13.59M | -19.79M | -1.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
CalciMedica announces board changes By Investing.com - Investing.com Australia
CalciMedica appoints new director amid clinical trials By Investing.com - Investing.com Nigeria
CalciMedica announces board changes - Investing.com
CalciMedica appoints new director amid clinical trials - Investing.com
CalciMedica Announces Board Changes and New Appointment - TipRanks
CalciMedica Strengthens Board with Biotech Veteran Dr. Glicklich Ahead of Auxora Phase 3 Trials - StockTitan
CalciMedica, Inc. (NASDAQ:CALC) Shares Acquired by Geode Capital Management LLC - Defense World
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - The Eastern Progress Online
CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - The Eastern Progress Online
CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Eastern Progress Online
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference - The Eastern Progress Online
Graybug Vision stock hits 52-week low at $2.65 amid market challenges - Investing.com Canada
CalciMedica Announces Presentations at Upcoming Medical Meetings - The Eastern Progress Online
CalciMedica director Fred Middleton buys $12,720 in stock By Investing.com - Investing.com Canada
CalciMedica director Fred Middleton buys $12,720 in stock - Investing.com
Atria Investments Inc Purchases 15,296 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World
CalciMedica to Present CRAC Channel Therapy Updates at Piper Sandler Healthcare Conference | CALC Stock News - StockTitan
Insiders Bet Big on These Small Cap Stocks - MSN
CalciMedica Launches $10M+ Public Stock Offering BIOPHARMA: Propelling Calcium-Based Drug Platform By JENNIFER KASTNER - San Diego Business Journal
CalciMedica’s (CALC) “Buy” Rating Reiterated at HC Wainwright - Defense World
Bkv Corp (BKV-N) QuotePress Release - The Globe and Mail
CalciMedica reports Q3 EPS (50c), consensus (50c) - TipRanks
CalciMedica's Auxora Shows 100% Risk Reduction in Respiratory Failure, Extends Cash Runway | CALC Stock News - StockTitan
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates - PR Newswire
CalciMedica Appoints Stephen Bardin as New CFO - TipRanks
CalciMedica Appoints Chief Financial Officer - Contract Pharma
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer - Citizentribune
CalciMedica director Fred Middleton acquires shares valued at $404,040 - Investing.com India
CalciMedica director Fred Middleton acquires shares valued at $404,040 By Investing.com - Investing.com Australia
CalciMedica sees significant stock purchase by Sanderling Ventures - Investing.com India
H.C. Wainwright cuts CalciMedica stock target to $16, keeps Buy rating - Investing.com Australia
Graybug Vision Suspends Stock Offering Amid Proposed Public Offering of CalciMedica - Defense World
Calcimedica director Robert Wilson acquires $199,998 in stock - Investing.com India
CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock By Investing.com - Investing.com Australia
CalciMedica CEO Rachel Leheny acquires $75,000 in common stock By Investing.com - Investing.com Australia
Calcimedica director Robert Wilson acquires $199,998 in stock By Investing.com - Investing.com Australia
Director Robert Wilson Acquires 53,333 Shares of CalciMedica Inc (CALC) - GuruFocus.com
CalciMedica CEO Rachel Leheny acquires $75,000 in common stock - Investing.com
CalciMedica's chief business officer Eric Roberts acquires $199,998 in stock - Investing.com
Finanzdaten der Calcimedica Inc-Aktie (CALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):